Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Invest Dermatol. 2011 Sep;131(9):1785-6. doi: 10.1038/jid.2011.200.

The dark side of regulatory T cells in psoriasis.

Author information

  • 1Department of Dermatology, Case Western Reserve University, University Hospitals Case Medical Center, Cleveland, Ohio 44106, USA.

Abstract

Psoriasis is a hereditary disease elicited by chronic activation of cutaneous T cells. Delineating the mechanistic interplay of the cell subsets involved is key to developing the next generation of effective treatments. In this issue, Bovenschen et al. report that regulatory T cells maintain a fine balance between the transcription factors Foxp3 and RORγt. In patients with psoriasis, Tregs readily turn into IL-17-expressing cells, thus potentially perpetuating the inflammatory process that characterizes the disease. Results demonstrating that the histone/protein deacetylation inhibitor trichostatin A can block this conversion suggest that an epigenetic modification may underlie regulatory T-cell plasticity.

PMID:
21844929
[PubMed - indexed for MEDLINE]
PMCID:
PMC3366427
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Write to the Help Desk